Purple Biotech (PPBT) Institutional Ownership $2.33 -0.03 (-1.06%) As of 09:50 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Purple Biotech (NASDAQ:PPBT)CurrentInstitutional OwnershipPercentage9.64%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$229.66KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$45.18K Get PPBT Insider Trade Alerts Want to know when executives and insiders are buying or selling Purple Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PPBT Institutional Buying and Selling by Quarter Purple Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/21/2025Kingswood Wealth Advisors LLC16,797$44K0.0%-50.0%1.262% 2/14/2025Two Sigma Securities LLC15,374$72K0.0%N/A1.156% 1/22/2025Kingswood Wealth Advisors LLC33,594$158K0.0%N/A2.526% 8/15/2024Armistice Capital LLC1,358,000$553K0.0%-35.8%5.381% 2/13/2024Armistice Capital LLC1,882,173$1.47M0.0%N/A8.544% 2/6/2024WuXi AppTec Co. Ltd.194,139$151K0.4%N/A0.881% 1/16/2024Kingswood Wealth Advisors LLC175,100$137K0.0%+34.0%0.795% 8/9/2023Kingswood Wealth Advisors LLC127,950$178K0.1%N/A0.692% 2/3/2023Fisher Asset Management LLC32,200$44K0.0%N/A0.183% 1/28/2022ARK Investment Management LLC662,499$2.58M0.0%-10.0%2.554% 11/15/2021Point72 Asset Management L.P.279,294$1.28M0.0%-46.8%1.077% 10/20/2021Venture Visionary Partners LLC10,068$46K0.0%N/A0.039% 8/16/2021Point72 Asset Management L.P.525,000$2.56M0.0%N/A2.024% 8/16/2021Morgan Stanley37,988$185K0.0%-77.4%0.146% 8/11/2021Condor Capital Management21,000$102K0.0%N/A0.081% 5/18/2021Morgan Stanley167,804$693K0.0%-66.1%0.958% 5/18/2021Orbimed Advisors LLC31,418$130K0.0%-90.9%0.179% 5/13/2021Renaissance Technologies LLC219,035$905K0.0%+69.9%1.251% (Data available from 1/1/2016 forward) PPBT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PPBT shares? During the previous two years, the following institutional investors and hedge funds held shares of Purple Biotech shares: Armistice Capital LLC ($553K), WuXi AppTec Co. Ltd. ($151K), and Two Sigma Securities LLC ($72K), Kingswood Wealth Advisors LLC ($44K).Learn more on Purple Biotech's institutional investors. What percentage of Purple Biotech's stock is owned by institutional investors? 9.64% of Purple Biotech's stock is owned by institutional investors. Learn more on PPBT's institutional investor holdings. Which institutional investors have been buying Purple Biotech's stock? The following institutional investors have purchased Purple Biotech's stock in the last 24 months: Armistice Capital LLC ($1.88M), Kingswood Wealth Advisors LLC ($205.99K), WuXi AppTec Co. Ltd. ($194.14K), and Two Sigma Securities LLC ($15.37K). How much institutional buying is happening at Purple Biotech? Institutional investors have bought a total of 48,968 shares in the last 24 months. This purchase volume represents approximately $229.66K in transactions. Which of Purple Biotech's major shareholders have been selling company stock? The following institutional investors have sold Purple Biotech stock in the last 24 months: Armistice Capital LLC ($757K), and Kingswood Wealth Advisors LLC ($16.80K). How much institutional selling is happening at Purple Biotech? Institutional investors have sold a total of 773,797 shares in the last 24 months. This volume of shares sold represents approximately $45.18K in transactions. Related Companies Eyenovia Institutional Ownership AlloVir Institutional Ownership Athira Pharma Institutional Ownership iBio Institutional Ownership Equillium Institutional Ownership Citius Pharmaceuticals Institutional Ownership Bright Green Institutional Ownership Phio Pharmaceuticals Institutional Ownership BioCardia Institutional Ownership Trinity Biotech Institutional Ownership This page (NASDAQ:PPBT) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PPBT Stock Alerts